A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: Results of a European LeukemiaNet (ELN) consensus process

Giovanni Barosi, Gunnar Birgegard, Guido Finazzi, Martin Griesshammer, Claire Harrison, Hans Hasselbalch, Jean Jacques Kiladijan, Eva Lengfelder, Ruben Mesa, Mary F. Mc Mullin, Francesco Passamonti, John T. Reilly, Alessandro M. Vannucchi, Tiziano Barbui

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)961-963
Number of pages3
JournalBritish Journal of Haematology
Volume148
Issue number6
DOIs
Publication statusPublished - 2010

Keywords

  • Hydroxycarbamide
  • Intolerance
  • Polycythaemia vera
  • Primary myelofibrosis
  • Resistance

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Barosi, G., Birgegard, G., Finazzi, G., Griesshammer, M., Harrison, C., Hasselbalch, H., Kiladijan, J. J., Lengfelder, E., Mesa, R., Mc Mullin, M. F., Passamonti, F., Reilly, J. T., Vannucchi, A. M., & Barbui, T. (2010). A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: Results of a European LeukemiaNet (ELN) consensus process. British Journal of Haematology, 148(6), 961-963. https://doi.org/10.1111/j.1365-2141.2009.08019.x